Copies of the prospectus supplement and the short form base shelf prospectus may be obtained from your registered financial advisor or from representatives of the Agent and are available on SEDAR at Story continues The ATM Program is being offered pursuant to a prospectus supplement dated Decemto the Company’s short form base shelf prospectus dated December 5, 2022. Since the Shares will be distributed at the prevailing market prices at the time of the sale, prices may vary among purchasers during the time of distribution. Sales of the Shares will be made by way of "at-the-market distributions" as defined in National Instrument 44-102 Shelf Distributions on the TSX or on any marketplace for the Shares in Canada. Sales of the Shares through the ATM Program will be made pursuant to the terms of an equity distribution agreement dated Decem(the "Equity Distribution Agreement") with National Bank Financial Inc. In order to seek to generate additional returns, Harvest may write call options each month in respect to some or all of the equity securities in the Portfolio. The Company intends to use the proceeds from the ATM Program in accordance with the investment objectives and strategies of the Company to invest in an equally-weighted portfolio of ten issuers comprised of equity securities selected by Harvest from a universe of pharmaceutical issuers. The ATM Program will be effective until January 6, 2025, unless terminated prior to such date by the Company. The volume and timing of the distributions under the ATM Program, if any, will be determined at Harvest’s sole discretion. This ATM Program replaces the prior program established in June 2021 that has terminated in accordance with its terms. ![]() Any Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the "TSX") or any other marketplace in Canada on which the Shares are listed, quoted or otherwise traded at the prevailing market price at the time of sale. ![]() (the "Company") (TSX:PRM) (TSX:PRM.PR.A) has established an at-the-market equity program ("ATM Program") that allows the Company to issue up to $75,000,000 of each of the Preferred Shares and the Class A Shares of the Company (together, the "Shares") to the public from time to time, at the discretion of Harvest. ("Harvest") is pleased to announce that Big Pharma Split Corp. OAKVILLE, Ontario, December 09, 2022-( BUSINESS WIRE)-Harvest Portfolios Group Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |